↓ Skip to main content

Dove Medical Press

Article Metrics

Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration

Overview of attention for article published in OncoTargets and therapy, March 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus
1 Google+ user
video
1 video uploader

Readers on

mendeley
18 Mendeley
Title
Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration
Published in
OncoTargets and therapy, March 2014
DOI 10.2147/ott.s59227
Pubmed ID
Authors

Long-Jun Dai, Zhuo-Shun Yang, Xiang-Yun Tang, Xing-Rong Guo, Dan-Dan Zou, Xu-Yong Sun, Jing-Bo Feng, Jie Luo, Garth L. Warnock

Abstract

Mesenchymal stem cells (MSCs) have been considered to hold great potential as ideal carriers for the delivery of anticancer agents since the discovery of their tumor tropism. This study was performed to demonstrate the effects of phosphatase and tensin homolog (PTEN) engineering on MSCs' capacity for cancer cell-oriented migration.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 50%
Lecturer 2 11%
Student > Bachelor 1 6%
Student > Doctoral Student 1 6%
Student > Master 1 6%
Other 1 6%
Unknown 3 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 22%
Agricultural and Biological Sciences 4 22%
Medicine and Dentistry 3 17%
Neuroscience 2 11%
Engineering 1 6%
Other 0 0%
Unknown 4 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2014.
All research outputs
#7,634,862
of 12,661,434 outputs
Outputs from OncoTargets and therapy
#424
of 1,585 outputs
Outputs of similar age
#92,297
of 190,940 outputs
Outputs of similar age from OncoTargets and therapy
#9
of 20 outputs
Altmetric has tracked 12,661,434 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,585 research outputs from this source. They receive a mean Attention Score of 2.3. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,940 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.